Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Aging mice have slower hair regeneration due to changes in signal balance, but the environment, not stem cell loss, controls this, suggesting treatments could focus on environmental factors.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Mutations in the DSG4 gene can cause a rare hair disorder similar to monilethrix.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Advanced human skin models improve drug development and could replace animal testing.

Some breast cancer chemotherapy can cause permanent hair loss.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

No cure for female pattern hair loss, but various effective treatments exist.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

Human hair follicle cells can grow hair when put into mouse skin if they stay in contact with mouse cells.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.